Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes

Table 5 The multiple regression analyses with fibrosis-4 and non-alcoholic fatty liver disease-fibrosis score as dependent variables in two models

	β (95%CI); t ratio	β (95%CI); t ratio
Model 1
Left atrium diameter	0.044 (0.007; 0.082); 2.307a	0.039 (0.004; 0.074); 2.180a
Right atrium diameter	0.019 (-0.014; 0.052); 1.107	0.041 (0.010; 0.072); 2.628b
Sex	0.137 (-0.273; 0.546); 0.654	-0.560 (-0.941; -0.179); 2.881b
Serum creatinine	0.748 (-0.025; 1.521); 1.897	1.467 (0.747; 2.186); 3.995c
Model 2
Left atrium diameter	0.037 (0.0005; 0.073); 1.990a	0.030 (-0.005; 0.065); 1.695
C-peptide	0.175 (0.071; 0.280); 3.282b	0.099 (-0.002; 1.200); 1.920
Right atrium diameter	0.013 (-0.017; 0.043); 0.851	0.030 (0.001; 0.059); 2.021a
Serum creatinine	0.410 (-0.328; 1.148); 1.089	0.843 (0.133; 1.533); 2.326a

^aP < 0.05.

^bP < 0.01.

^cP < 0.0001.

Independent variables in Model 1: Left ventricular mass index (LVMi), left atrium diameter, right atrium diameter, sex, smoking status, systolic blood pressure, duration of diabetes, alcohol intake, atrial fibrillation, serum creatinine; in Model 2: LVMi, left atrium diameter, right atrium diameter, C-peptide, low-density lipoprotein cholesterol, serum creatinine). Only the parameters correlated with at least one score are mentioned in the table. 95%CI: 95% confidence interval; IV: Interventricular; LV: Left ventricle; LVMi: Left ventricular mass index; EF: Ejection fraction.